Generation of monoclonal antibodies to cancer/testis (CT) antigen CT10/MAGE-C2

Zhuang R., Zhu Y., Fang L., Liu X., Tian Y., Chen L., ...More

Cancer Immunity, vol.6, 2006 (Scopus) identifier identifier

  • Publication Type: Article / Article
  • Volume: 6
  • Publication Date: 2006
  • Journal Name: Cancer Immunity
  • Journal Indexes: Scopus
  • Acibadem Mehmet Ali Aydinlar University Affiliated: No


CT10/MAGE-C2 is a recently identified antigen that, typically of cancer/testis (CT) antigens, can be found in various malignant tumors and in normal adult testis. As with many other CT antigens, our knowledge is based mainly on mRNA expression data. In the present study, we describe the generation of mAbs to CT10/MAGE-C2 for the analysis of its protein expression. Newly generated clones were chosen based on their reactivity in ELISA, immunoblotting, and immunohistochemistry (IHC). Emphasis was put on the reactivity of newly generated reagents on formalin-fixed, paraffin-embedded tissue to ensure their applicability to archival material. Eventually we selected two clones, LX-CT10.5 and LX-CT10.9, that showed intense reactivity to CT10/MAGE-C2 protein and CT10/MAGE-C2 mRNA-positive cell lines, but no cross-reactivity with other CT antigens. Both mAbs show superior staining characteristics in IHC and are applicable to frozen and paraffin sections. In testis, CT10/MAGE-C2 displays the typical CT pattern with regard to staining of germ cells, which is intense during the early maturation stages. In tumors, we analyzed a limited number of cases displaying the typical heterogeneous CT expression pattern. Interestingly, immunoreactivity was seen solely in the nucleus: No staining was seen in the cytoplasm of tumor cells. © 2006 by Boquan Jin.